Development is first step to helping children with the rare epilepsy syndrome.

An international group of experts suggests an approach to study seizures that could help propel understanding of epilepsy forward.

SCN8A encephalopathy could be improved with a treatment already approved for other uses.

A new clinical trial in the emergency department finds no difference in efficacy or adverse effects of three commonly used treatments for patients with refractory status epilepticus.

New stem cell research reveals dangerous cardiac effects of a gene mutation in patients with Dravet syndrome.

People with medication-resistant epilepsy haven’t had many options. Now, a minimally invasive procedure uses lasers to stop the seizures.